Emprego da Lâmina de Imunofluorescência na ... - NewsLab

40. Osano E et al. Molecular characterization of an enterobacterial metallo-β-lactamase found in a clinical isolate of Serratia marcescens
that shows imipenem resistance. Antimicrob Agents Chemother. 38: 71-78, 1994.
41. Palleroni NJ. Introduction to the aerobic pseudomonads. In: Colier L, Balows A, Sussman M (eds). Topley & Wilson’s microbioloagy and
microbial infection- Systematic bacteriology. 2: 1091-1108, 1998.
42. Paterson DL. Looking for risk factors for the acquisition of antibiotic resistance: a 21st-century approach. Clin Infect Dis. 34: 1564-7,
2002.
43. Patzer J et al. Pseudomonas aeruginosa strains harbouring an unusual blaVIM gene Cassette isolated from hospitalized children in
Poland (1998-2001). J Antimicrob Chemother. 53: 451-456, 2004.
44. Quinteira S et al. Characterization of in 100, a new integron carrying a metallo-β-lactamase and a carbenicillinase, from Pseudomonas
aeruginosa. Antimicrob Agents Chemother. 49: 151-153, 2005.
45. Pellegrino FL et al. Occurrence of a multidrug-resistant Pseudomonas aeruginosa clone in different hospitals in Rio de Janeiro, Brazil. J
Clin Microbiol,. 40: 2420-2424, 2002.
46. Pitout JDD, Gregson DB, Poirel L, Mcclure JA, LE P, Church DL. Detection od Pseudomonas aeruginosa producing metallo-β-lactamases
in a large centralized laboratory. Journal of Clinical Microbiology. 43: 3129-3135, 2005.
47. Poolack M. Pseudomonas aeruginosa. In: Mandell D, Benneth J, Dolin R (eds). Principles and practice of infection diseases, 1995.
48. Poirel L, Nordmann P. Acquired carbapenem-hydrolyzing β-lactamases and their genetic support. Curr Pharm Biotechnol. 3: 117-127,
2002.
49. Poirel L et al, Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from
a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother. 44: 891-897, 2000.
50. Rahman MM, Haq JA, Hossain MA, Sultana R, Islam F, Islam AH. Prevalence of extended-spectrum beta-lactamase-producing Escherichia
coli and Klebsiella pneumoniae in an urban hospital in Dhaka, Bangladesh. Int J Antimicrob Agents. 24(5): 508-10, 2004.
51. Riccio ML et al. Clonal relatedness and conserved integron structures in epidemiologically unrelated Pseudomonas aeruginosa strains producing
the VIM-1 Metallo-β-lactamase from different Italian hospitals. Antimicrobial Agents and Chemotherapy. 49: 104-110, 2005.
52. Rossi F, Andreazzi D. Resistência bacteriana: interpretando o antibiograma. São Paulo:Editora Atheneu; 2005. p. 65-91.
53. Rossolini GM et al. Characterization and sequence of the Chryseobacterium (Flavobacterium) meningosepticum carbapenemase: a
new molecular class B β-lactamase showing a broad substrate profile. Biochem J. 332: 145-152, 1998.
54. Sader HS, Jones RN, Gales AC, Silva JB, Pignatari AC. Sentry. Antimicrobial Surveillance Program report: Latim American and Brazilian
results for 1997 through 2001. Braz Infect Dis, 8: 25-79, 2004.
55. Sader HS, Reis AO, Silbert S, Gales AC. IMPs, VIMs and SPMs: the diversity of metallo-β-lactamases produced by carbapenem-resistant
pseudomonas aeruginosa in a Brazilian hospital. Clin Microbiol Infect. 11: 73-76, 2005.
56. Santos Filho L et al. Determinação da produção de metalo-beta-lactamases em amostras de Pseudomonas aeruginosa isoladas em
João Pessoa, Paraíba. J. Bras. Patol. Med. Lab., Rio de Janeiro, 38(4): 291-296, 2002.
57. Simm AM et al. A novel metallo-β-lactamase, Mbllb, produced by the environmental bacterium Caulocacter crescentus. FEBS Lett. 509:
350-354, 2001.
58. Speldooren V et al. Discriminatory detection of inhibitor-resistant beta-lactamases in Escherichia coli by single-strand conformation
polymorphism-PCR. Antimicrob. Agents Chemother., 42(4): 879-884, 1998.
59. Spencer J et al. Novel mechanism of Hydrolysis of therapeutic β-lactams by Stenotrophomonas maltophilia LI metallo-β-lactamase. J
Biol Chem. 276: 33638-11, 2001.
60. Toleman MA et al. Molecular characterization of SPM-1, a novel metallo-β-lactamase isolated in Latin America: report from the Sentry
Antimicrobial Surveillance Program. Journal of Antimicrobial Chemotherapy, 50(5): 673-9, 2002.
61. Toleman AM, Biedenbach D, Bennett DMC, Jones RN, Walsh TR. Italian metallo-ß-lactamases: a national problem? Report from the
Sentry Antimicrobial Surveillance Programme. Journal of Antimicrobial Chemotherapy. 50(1): 61-70, 2005.
62. Tsakris A et al. Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J Clin Microbiol,
38: 1290-2, 2000.
63. Woodford N et al. Carbapenemases of Chryseobacterium (Flavobacterium) meningosepticum: distribution of blab3 in the type strain,
NCTC 10016. Antimicrob. Agents Chemother. 44: 1448-1452, 2000.
64. Yan JJ et al. Comparison of the double-disk, combined disk and E-test methods for detecting metallo-β-lactamases in gram-negative
bacilli. Diag Microbiol Infect Dis. 49: 5-11, 2004.
65. Yum JH et al. Molecular characterization of metallo-β-lactanase-producing Acinetobacter Baumannii and Acinetobacter genomospecies
3 from Korea: identification of two new integrons carrying the blavim-2 cassetes. Journal of Antimicrobial Chemotherapy. 49: 837-840,
2002.
66. Zavaski AP, Gaspareto PB, Martins AF, Gonçalves AL, Barth AL. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing
SPM-1 metallo-β-lactamase in a teaching hospital in southern Brazil. Journal of Antimicrobial Chemotherapy, 56: 1148-1151, 2005.
112
NewsLab - edição 91 - 2008